CEO Chris Green told Axios Pro: Xapien raised $56M in a Series B led by Spectrum Equity. The company sells software that researches people and businesses before an organization accepts a client, engages a supplier or takes a donation. Its users include compliance teams, law firms and nonprofit researchers who need more than a name matching an entry in a database.
The workflow starts with identifying the subject. Xapien says its software brings together public and commercial information, distinguishes relevant records from misleading matches, and produces a report with sources attached. A team can review and edit the findings, ask follow-up questions and share the report before making an approval decision. For a business checking a prospective partner, the point is to understand the relationship behind a record, not simply receive a list of search results.
Xapien packages that work as annual software plans organized around report volumes. Its published plans start at 250 reports a year, with larger arrangements for teams doing more research and separate options for nonprofits. Prices are negotiated rather than displayed as a fixed public rate. The business therefore depends on becoming part of a recurring review process, rather than selling a single investigation whenever an unusual transaction appears.
Its partnership with BWF shows how the same research engine can serve a different buyer. BWF advises philanthropic organizations; the partners describe using Xapien to investigate prospective donors and flag legal, regulatory or reputational concerns. A university considering a major gift, for example, can use that research as an input to deciding whether the association fits its standards. BWF contributes advice and fundraising expertise, while Xapien supplies the research capability; the partnership is not evidence that every BWF client uses the software.
Xapien's product also makes room for configurable review rules and collaboration among staff. That matters because identifying an adverse report is not the same as deciding whether it concerns the right person or should prevent a relationship. The company promises faster research, but its broad accuracy claims are vendor assertions, not an independent guarantee. The durable test for this business is whether organizations can process more relationships while retaining a defensible trail from each finding to the evidence and the person responsible for the decision.